In this week's Liberty Update we highlight the potentially catastrophic threat of H.R. 3, the healthcare…
CFIF on Twitter CFIF on YouTube
Quote of the Day: WSJ on H.R. 3, Biden & Pelosi's Dangerous Healthcare Bill

In this week's Liberty Update we highlight the potentially catastrophic threat of H.R. 3, the healthcare and drug price control bill that Joe Biden and Nancy Pelosi are attempting to rush through Congress.  The Wall Street Journal helpfully offers further insight this morning on how H.R. 3 would threaten lifesaving U.S. pharmaceutical innovation and leadership, including on things like the Covid vaccines:

 

Companies that refuse the government’s price must pay a 95% excise tax on all revenue they generate from that drug in the U.S.  They’d also have to offer the government price to private insurers.  There’s no “negotiation” when a gun is pointed at your head.  A new study in the Journal of the American Medical Association estimates that drug spending in the U.S…[more]

September 17, 2021 • 12:55 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
CFIF Submits Formal Comment on NIST Proposed Rule Regarding Bayh-Dole Act of 1980 Print
By CFIF Staff
Monday, April 12 2021

Last week, the Center for Indvidiual Freedom (CFIF) submitted a formal Comment with the U.S. Commerce Department's National Institute of Standards and Technology (NIST) on its Proposed Rule regarding the Bayh-Dole Act of 1980, which granted universities, nonprofit organizations and small business the right to patent and license inventions funded partly by federal funding. 

The Economist magazine called the Bayh-Dole Act "Possibly the most inspired piece of legislation to be enacted in America over the past half century," and rightfully so.  It unleashed a tidal wave of hundreds of thousands of patents issued to American universities and research institutes since then. 

On that basis, CFIF supports the Proposed Rule to the extent that it advances the provisions and intent of Bayh-Dole, with the caveat that insertion of the terms "exclusively" and "of the contractor" in the Proposed Rule's text may open the door for advocates of drug price controls to suggest that business decisions of pharmaceutical innovators regarding the pricing of commercial goods and services arising from the practical application of inventions may serve as one basis for exercising march-in rights.  Neither the text nor the intent of the Bayh-Dole Act allow that, as namesake Senators Bayh and Dole themselves pointed out in a joint statement to The Washington Post

On that basis we urge that the Proposed Rule omit those terms.  We must ensure that Bayh-Dole's four-decade legacy of incredible success continues, without the looming threat that activists may attempt to use it to impose destructive drug price controls on American consumers.

Read CFIF's comment here (PDF).

Related Articles :
Quiz Question   
Based on FBI statistics, what is the approximate annual cost to U.S. victims of cyber-crime?
More Questions
Notable Quote   
 
"Nearly two years after evidence emerged that the infamous Steele dossier was a political dirty trick filled with Russian disinformation and disproved allegations, Special Counsel John Durham unloaded a new indictment that exposes a parallel effort by Hillary Clinton's campaign to flood the FBI with more dubious Trump-Russia collusion dirt.In painstaking detail, Durham laid out in the indictment Thursday…[more]
 
 
—John Solomon, Investigative Journalist, Author, and Chief Executive Officer and Editor in Chief of Just the News
— John Solomon, Investigative Journalist, Author, and Chief Executive Officer and Editor in Chief of Just the News
 
Liberty Poll   

Of the presidents who have presided over the Afghanistan war, which one deserves the worst grade as the U.S. observes the 20th anniversary of 9-11?